RLYB logo

Rallybio Corporation Common Stock


RLYB: Rallybio Corp is a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its lead program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.


Show RLYB Financials

Consumer Interest
SEC Filings

Recent trades of RLYB by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by RLYB's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of RLYB in WallStreetBets Daily Discussion


Recent insights relating to RLYB

CNBC Recommendations

Recent picks made for RLYB stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RLYB

Corporate Flights

Flights by private jets registered to RLYB